Contrast

Contact

Share

Donate

MyChart

Help

YNHH Auxiliary awards scholarships to local students

NEW HAVEN, CT, June 18, 2015 – The Yale New Haven Hospital Auxiliary has announced its scholarship winners for 2015. 

At a dinner held May 20 at the Farms Country Club in Wallingford, YNHH Auxiliary Scholarship Committee Chair Dolores Zamparo presented $1,500 scholarships to eight local students who will pursue an education in the medical and allied health fields.  

Scholarship winners were Amanda Pinto of Guilford (Guilford High School); Kathryn Stufano of Madison (Daniel Hand High School); Kaleigh DeBowes of West Haven (Sacred Heart Academy); Anthony Richardson of West Haven (Notre Dame High School); Dana Chung of Orange (Amity Regional High School); Madison Smith and Zachary Sola, both of Wallingford (Lyman Hall High School); and Sabrina Maher of Orange (University of Connecticut).   

Since 1953, the YNHH Auxiliary has donated millions of dollars toward hospital programs, services, scholarships, and health education in the community, and made major contributions that most recently included a $1 million pledge to be divided equally between the YNHH Musculoskeletal Center and the Obstetrical and Neonatal Intensive Care Units (NNICU) projects. The organization supports a wide variety of programs that continually benefit hospital programs and community outreach efforts, from providing age-appropriate toys to pediatric patients through the Toy Closet program to community-based health education programs. The Auxiliary Board is composed of community leaders, corporate executives, professionals, dedicated parents and employees, all committed to helping Yale New Haven Hospital serve its patients, families and community better.

For more information about the YNHH Auxiliary and how you can help, contact [email protected] or 203-688-5717. 

Yale New Haven Hospital is a nationally recognized, 1,541-bed, not-for-profit hospital serving as the primary teaching hospital for the Yale School of Medicine. Yale New Haven was founded as the fourth voluntary hospital in the U.S. in 1826 and today, the hospital’s two New Haven-based campuses include Yale New Haven Children's Hospital, Yale New Haven Psychiatric Hospital and Smilow Cancer Hospital. YNHH has a combined medical staff of about 4,500 university and community physicians practicing in more than 100 specialties. YNHH’s York Street campus and associated ambulatory sites are Magnet-designated by the American Nurses Credentialing Center. www.ynhh.org

Yale New Haven Hospital (YNHH), part of Yale New Haven Health, is a nationally recognized, 1,541-bed, not-for-profit hospital serving as the primary teaching hospital for the Yale School of Medicine (YSM). Founded as the fourth voluntary hospital in the U.S. in 1826, today, YNHH has two New Haven-based campuses, and also includes Yale New Haven Children's Hospital, Yale New Haven Psychiatric Hospital and Smilow Cancer Hospital. YNHH has received Magnet designation from the American Nurses Credentialing Center, the nation’s highest honor of nursing excellence. YNHH has a combined medical staff of about 4,500 university and community physicians practicing in more than 100 specialties. www.ynhh.org

Similar Articles

9/15/2021

Marna Borgstrom to retire in 2022 as CEO of Yale New Haven Health

New Haven, CT (Sept. 15, 2021) – After more than 43 years of exceptional service, Marna P. Borgstom has announced her intent to retire as chief executive officer of Yale New Haven Health. Her retirement is effective on March 25 2022.

9/15/2021

Christopher O’Connor to become CEO of Yale New Haven Health

New Haven, CT (Sept. 15, 2021) – Christopher O’Connor has been named the CEO of Yale New Haven Health (YNHHS), effective March 25, 2022 when current CEO Marna P. Borgstrom retires, announced Vince Calarco, Chair of the YNHHS Board of Trustees. O’Connor currently serves as president of the Health System having been named to that position in August of 2020.

9/1/2021

Outpatient Monoclonal Antibody Treatment decreases hospitalization risk in COVID-19 patients

New Haven, CT (September 1, 2021) – While not a new treatment, monoclonal antibody therapy is being administered more regularly and effectively to patients with mild to moderate COVID-19 with excellent results.